Genomic Expression, Inc. — Form C-U (Regulation Crowdfunding)
Genomic Expression, Inc. of BEVERLY, MA filed a Form C-U (Regulation Crowdfunding) with the SEC on 2025-02-11. Target raise $15K, up to $1.2M. Offered through StartEngine Capital, LLC.
Offering
- Filed: 2025-02-11
- Form: C-U
- Accession: 0001665160-25-000232
- Target amount: $15K
- Maximum amount: $1.2M
- Security type: Other
- Securities offered: 15,000
- Deadline: 2025-02-06
- Funding portal / intermediary: StartEngine Capital, LLC
- Intermediary file number: 007-00007
Issuer
- CIK: 0001611868
- Website: https://genomicexpression.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2009-07-01
- Address: 100 CUMMINGS CENTER, SUITE 451C,, BEVERLY, MA, 01915
- Employees: 5
Financials (as filed)
- Total assets (most recent): $1.0M
- Cash (most recent): $61K
- Revenue (most recent): $223K
- Revenue (prior): $608K
- Net income (most recent): $-274K
- Net income (prior): $-127K
- Short-term debt: $288K
- Long-term debt: $473K
People (4)
| Name | Role | Location |
|---|
| Gitte Pedersen | CEO, Principal Accounting Officer, and Chairman of the Board | New York, NY |
| Dr. Morten Lorentz Pedersen | Director, CSO and co-founder | BEVERLY, MA |
| Dr. Morten Lorentz Pedersen | Director, CSO and Co-Founder | BEVERLY, MA |
| Kirsten Dinesen | Director | BEVERLY, MA |
Reg CF filing history (5)
More